Moponetug
莫波奈塔单抗
Report date: 2026/04/16 20:00:17
Base Information
Drug NameMoponetug
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[10]
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesProthena
China Registration ClassN/A
Develop Information
Active CompaniesBristol Myers Squibb SrlcompanyProthena
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A